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O pen tibial shaft fracture is the most common open long-bone fracture because of its location and tenuous soft tissue coverage. 1 The incidence rate has been reported to be as high as 2.8 to 5/100,000 2, 3 and shows an increasing trend due to road traffic accidents and firearm injuries. Treatment of open tibial shaft fractures continues to be associated with high rates of delayed union and nonunion, [4] [5] [6] and the prevalence reported in the literature ranges from 16% to 100% for different severe fractures. [6] [7] [8] Delayed healing of open tibial shaft fractures is associated with reduced functional outcome and quality of life, a higher rate of secondary intervention, and a higher infection rate. 5, [9] [10] [11] Thus, the goal of initial fracture treatment should be to increase the likelihood of union and reduce risk and cost.
Recombinant human bone morphogenetic protein-2 (rhBMP-2) is an osteoinductive protein. In preclinical and human studies, rhBMP-2 has been shown to induce bone formation, [12] [13] [14] which is integrated with surrounding bone via bone remodeling. 15 Well-designed studies have reported the use of rhBMP-2 combined with absorbable collagen sponge (rhBMP-2/ACS) in open tibial shaft fractures to promote fracture healing. 9, 16, 17 However, the results were controversial. Govender et al 17 reported a lower infection rate in an rhBMP-2/ACS group (23%) vs a standard-of-care (SOC) group (27%), whereas Aro et al 16 reported a higher infection rate in an rhBMP-2/ACS group (19%) vs an SOC group (11%). Also, hardware failure rates were controversial between the 2 studies. 16, 17 The purpose of the current study was to identify and summarize the evidence from randomized, controlled trials on the functional outcomes of open tibial shaft fractures treated with and without rhBMP-2.
Materials and Methods

Study Selection
Standard systematic review methods were used. Initially, a prospective protocol was written to describe the objectives, search criteria, study selection criteria, data elements of interest, and plans for analysis. The electronic databases Medline, EMBASE, CINAHL, and Cochrane Central Register of Controlled Trials, last updated on January 20, 2012, were searched without limits. The words rh-BMP-2 and tibia* were searched in the titles, abstracts, and Medical Subject Headings. Major orthopedic surgery journals were reviewed. A manual reference check of all accepted papers and recent reviews was performed to supplement the electronic searches and identify any additional potentially relevant studies. Two reviewers (S.W., J.H.) screened the titles and abstracts of potentially relevant articles. Protocol-defined data elements from each eligible study were extracted and confirmed by 2 reviewers (X.L., Q.W.). Differences were resolved prior to data entry. In cases of disagreement, a third reviewer was consulted (X.C.) and a decision was made through discussion.
Inclusion and Exclusion Criteria
Inclusion criteria included (1) prospective randomized, controlled trials comparing functional outcomes of open tibial shaft fractures treated with and without rhBMP-2; (2) all patients treated with intramedullary nail fixation (reamed or unreamed) no longer than 14 days after injury; (3) in the rhBMP-2 treatment group, only patients treated with 1.50 mg/mL of rhBMP-2; (4) comparable baseline characteristics between groups, including age, sex, tobacco use, and open fracture classification; (5) >10 patients in each treatment group; and (6) at least 1-year follow-up. Exclusion criteria included (1) retrospective or nonrandomized control trails; and (2) trials in which the treatment allocation was inadequately concealed. In cases of multiple publications on the same patient population, only the higher protocolrelevant study or patient population was included. The Jadad scale, which scores randomization, double blinding, and withdrawal, was used to evaluate the methodological quality of the trials. 18 Scores range from 0 (poorest) to 5 (best) ( Table 1) .
Data Sampling
The data extracted for the meta-analysis included secondary intervention, treatment failure, infection, fracture healing time, and pain level. Secondary intervention meant a recommendation for an intervention to promote fracture union. Treatment failure meant no secondary intervention and fracture nonunion, secondary intervention and union, or secondary intervention and fracture nonunion. Infection included deep and superficial infections. Fracture healing rates at different time points were 
Statistical Analysis
Review Manager version 5.0 for Windows statistical software (Cochrane Collaboration, Copenhagen, Denmark) was used for the meta-analysis. For continuous variables, using the same measurement unit, outcomes were analyzed by weighted mean difference; for dichotomous variables, risk ratio and 95% confidence interval (CI) were used. Heterogeneity was tested with the Cochrane Q test (a50.05). If the heterogeneity was significant, a random effects model resulting in wider CI was used; if not, a fixed effects model was used. The z test was used to test overall effects. Significance levels for all statistical tests were set a priori to a50.05. Data that could not be incorporated into the metaanalysis were summarized without statistical analysis. The results of meta-analysis were explained by forest plot.
results
Literature Search and Study Characteristics
The primary search generated a total of 65 results, of which 61 were excluded. Four studies with a total of 609 patients were included in this systematic review and metaanalysis ( Figure 1) . 2, 9, 16, 17 Demographic data and methodological quality scores of the included studies are shown in Table 2 . One study comprised a total of 338 patients, of which 299 patients were considered an overlap, and only the demographic data of the 39 new patients were calculated. The rhBMP-2/ACS treatment group had a mean age of 36.3 years (range, 18-77 years), and 85% of the patients were men. The SOC group had a mean age of 36.9 years (range, 17-87 years), and 81% of the patients were men. No differences existed in demographic data between the 2 treatment groups (Table 3) .
Outcomes
Two studies were included in the metaanalysis of overall outcomes, 16, 17 and the major endpoints and results of the included studies are shown in Table 4 . A total of 123 (22.3%) patients required secondary intervention. Pooled results showed that the rate in the SOC group was significantly higher than in the rhBMP-2/ACS group (27.1% vs 17.5%, respectively; P,.01) ( (Figure 2 ).
Outcomes in Reamed Patients
Two studies on the outcomes of reamed patients were included (Table 4) . 9, 16 A total of 45 (11.5%) patients required secondary intervention, but the rates between the rhBMP-2/ACS and SOC groups did not reach statistical significance (10.3% vs 12.9%, respectively; P5.43). However, the total secondary intervention rate in the reamed patients was significantly lower than in the overall patient group (11.5% vs 22.3%, respectively; z54.09; P,.01). A total of 69 patients (17.7%) were considered to be treatment failures, and the rate in the SOC group was significantly higher than in the rhBMP-2/ACS group ( Figure 3 .
Health Economic Outcomes
One study with 122 Gustilo-Anderson grade III fractures evaluated health economic outcomes. 2 The analysis entailed assessing the financial savings in grade IIIA and B open tibial shaft fractures that could be achieved in the United Kingdom, Germany, and France by reduced secondary treatment costs over 1 year due to rhBMP-2 use. Direct health care costs and productivity losses represented a societal perspective for this health economic assessment. In the United Kingdom, with a product price of €2238, additional rhBMP-2 treatment led to net savings of €5673 per case in GustiloAnderson grade III open tibial shaft fractures compared with the control group. In Germany and France, the use of rhBMP-2 led to net savings of €6300 and €6341 per case, respectively. 
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Healio.com The new online home of ORTHOPEDICS | Healio.com/Orthopedics n Feature Article However, the delayed fracture healing rate is still high and is associated with a high secondary intervention rate. To the authors' knowledge, a meta-analysis of the use of rhBMP-2 in open tibial shaft fractures has not been previously performed, and the current study is the first to report on meta-pooled results comparing functional and economic outcomes. According to the current study, the use of rhBMP-2/ ACS could significantly decrease the secondary intervention rate of open tibial shaft fractures treated with intramedullary nail fixation. Also, a lower treatment failure rate was seen in the rhBMP-2/ACS group. These findings verify the conclu- sion of the BESTT study 17 of 450 patients with open tibial shaft fractures, in which rhBMP-2 was associated with improvement in multiple measures of healing compared with the standard of care in a population of patients treated with reamed or unreamed intramedullary nailing.
However, no significant difference was seen in infection rate between groups. This was controversial in the BESTT study, which reported a lower infection rate in the rhBMP-2/ACS group due to rhBMP-2-induced new bone and increased vascular supply.
17 Current large-sample meta-analysis results imply that early soft tissue management is still the most important procedure. 7 Although the current study tried to achieve better results, the infection rate was still high in both treatment groups (21% in the rhBMP-2/ACS group vs 19% in the SOC group).
According to the meta-analysis of Bhandari et al, 11 intramedullary nailing is superior to other fixation methods in the treatment of open tibial shaft fractures. However, reaming may independently affect the primary outcome of intramedul- [19] [20] [21] [22] [23] [24] [25] [26] However, one randomized, controlled trial reported no clinically important differences between the reaming and nonreaming groups with regard to the technical aspects of the procedure or the rate of early postoperative complications, and significantly more screws broke in the nonreaming group than in the reaming group. 27 Ziran et al 3 also reported a significant increase in the number of secondary procedures required to achieve union with the unreamed nailing technique. Two studies evaluated the economics of reamed vs unreamed intramedullary nailing, and both favored the reamed method for a lower cost. 28, 29 In one study, economic analysis from a governmental perspective suggested small differences in cost and effectiveness between reamed and unreamed intramedullary nailing, but the conclusion was uncertain. 30 Ziran et al 3 reported that patients receiving unreamed nailing incurred a cost of $4,900 more per fracture than patients undergoing the reamed-to-fit technique. According to the results of the current study, reamed patients have a lower treatment failure rate, and no significant differences were observed for other endpoints.
For health care economic analysis, one study reported that the use of rhBMP-2 leads to savings of €5697 and €3183 per patient for Gustilo-Anderson grade IIIB and all grade IIIA and B injuries, respectively. 31 The study concluded that these savings were mainly due to reduced sickness payments because of faster fracture heal- The strengths of the current study are the large sample size of the meta-analysis; its high internal validity through strategies to reduce bias, including centralized randomization of patients to ensure concealment and adjudication of outcome events; and a wide range of measured endpoints (eg, secondary intervention, treatment failure, infection, fracture healing time, pain level, and cost). The reamed patients were subgroup analyzed to eliminate the influence of reaming to the primary outcome. The authors acknowledge the possibility of a short-term bias because the included studies were constrained to the follow-up time of 1 year. However, the time horizon of 1 year appears reasonable 
conclusion
The findings of the current study confirm that rhBMP-2 in an absorbable collagen sponge could decrease the secondary intervention rate and the treatment failure rate when used with intramedullary nail fixation for the treatment of open tibial shaft fractures. The authors support the use of the reaming technique because of lower treatment failure rates. Because the waiting lists for surgical procedures are long in most countries and health care costs continue to increase, procedures that could prevent reoperations and reduce costs are important. 
